NCT06366243View on ClinicalTrials.gov

A Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Emraclidine in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions
Healthy Participants
Interventions
DRUG

Emraclidine

Oral tablet

DRUG

Esomeprazole

Oral delayed-release capsule

Trial Locations (1)

56529

Dilworth, Minnesota, Dilworth

Sponsors
All Listed Sponsors
lead

Cerevel Therapeutics, LLC

INDUSTRY

NCT06366243 - A Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Emraclidine in Healthy Adult Participants | Biotech Hunter | Biotech Hunter